Anti Cancer

Showing 17–32 of 40 results

Ibruxen 140 mg (Ibrutinib)
Read more
Lenvaxen 4 mg (Lenvatinib)
Read more
Lorbrexen 100 mg (Lorlatinib)
Read more
Mobonib 40 mg (Mobocertinib)
Read more
Niranib 100 mg (Niraparib)
Read more
NiVamo 40 Mg (Nivolumab)
Read more
Olakin 150 mg (Olaparib)
Read more
Olanib 50 mg (Olaparib)
Read more
Osicent 80 mg (Osimertinib)
Read more
Osikin 80 mg (Osimertinib)
Read more
Osimert 80 mg (Osimertinib)
Read more
Osinib 80 mg (Osimertinib)
Read more
Osmigen 80 mg (Osimertinib)
Read more
Ponaxen 15 mg (Ponatinib)
Read more
Prostaxen 60 mg (Apalutamide)
Read more
Sotakras 120 mg (Sotorasib)
Read more

←
1
2
3
→

Onco Medi Cure is dedicated to advancing cancer care through innovative medical solutions, compassionate support, and evidence-based treatments. We strive to bring hope and healing to patients by combining cutting-edge oncology practices with a patient-first approach.

Our Main Office

Dhaka, Bangladesh
01876888861
oncomedicure@gmail.com

Anti Cancer

Ibruxen 140 mg (Ibrutinib)

Lenvaxen 4 mg (Lenvatinib)

Lorbrexen 100 mg (Lorlatinib)

Mobonib 40 mg (Mobocertinib)

Niranib 100 mg (Niraparib)

NiVamo 40 Mg (Nivolumab)

Olakin 150 mg (Olaparib)

Olanib 50 mg (Olaparib)

Osicent 80 mg (Osimertinib)

Osikin 80 mg (Osimertinib)

Osimert 80 mg (Osimertinib)

Osinib 80 mg (Osimertinib)

Osmigen 80 mg (Osimertinib)

Ponaxen 15 mg (Ponatinib)

Prostaxen 60 mg (Apalutamide)

Sotakras 120 mg (Sotorasib)

Our Main Office

Menu

Category